Mutation Research/Reviews in Mutation Research
ReviewCandidate gene studies in gallbladder cancer: A systematic review and meta-analysis
Introduction
Gallbladder cancer (GBC) is the most frequent biliary tract malignancy and the fifth most common malignant neoplasm of the digestive tract [1]. Despite recent advances in the diagnosis and management of gastrointestinal cancers, GBC remains a challenging tumour with a poor overall prognosis. Many of these tumours are not resectable at the time of presentation, and the 5-year survival rate is <10% in most of the reported series [2]. GBC incidence varies greatly throughout the world, highest being in Native American and South American populations, and people from Poland and Northern India. Between 17,000 and 18,000 new cases of GBC are diagnosed in India each year, and the annual death rate is almost comparable [3]. The frequency increases with age and reaches to peak during the seventh and eighth decades of life [4]. GBC incidence also shows striking gender bias and affect females 2–3 times more frequently than males [4].
Several epidemiological studies have been conducted to estimate the effects of environmental factors on GBC risk to elucidate the large ethnic variations in risk [5], [6]. Yet, no single environmental factor has persistently been linked with GBC risk. It has been observed that Indian migrants to different countries have a higher risk of acquiring GBC as compared to the respective native populations [7]. Thus, the wide geographical, ethnic and interindividual variations observed in the incidence of GBC suggest the involvement of a genetic component in its etiopathogenesis.
The discovery of common genetic polymorphisms in human DNA has led to the publication of a large number of association studies in GBC [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [56]. However, a number of contradictory findings have been reported, and in several cases it has proved difficult to reproduce initial results. Also due to the high false positive associations, the possibility of a true association is well dependent on the quality of the studies concerned [31]. The major flaw with the individual studies is small sample sizes and therefore insufficient statistical power to detect positive associations and incapability to demonstrate the absence of an association. This necessitates the use of meta-analysis to provide an integrative approach by pooling the results of independent analyzes, thereby increasing statistical power and resolution [32], [33], [34], [35]. Thus, to get a better insight in the GBC pathogenesis, the present study was undertaken to explore the role of candidate gene polymorphisms in GBC susceptibility by applying a meta-analytical approach and systematically reviewing the available data.
Moreover, to draw a preliminary conclusion, we also carried out a systematic quality review of the published literature on genetic association studies in GBC. This was accomplished by strictly following the various guidelines and checklists that have been published on the conduct of genetic association studies in complex diseases [36], [37], [38], [39]. Using the criteria as described by Clark and Baudouin [40], we analyzed each publication to highlight the quality issues in the conduct and interpretation of these studies and also to establish if the existing data supports any polymorphism to be conclusively associated with GBC.
Section snippets
Literature search
Studies were selected by searching PubMed for articles listed from 2000 until March 2011 using the strategy outlined below:
- 1.
Restriction fragment length polymorphism/OR genetic polymorphism/OR single nucleotide polymorphism/OR DNA polymorphism/OR genetic variation.
- 2.
Genetic association/.
- 3.
Single nucleotide polymorphism/OR SNP.
- 4.
Gallbladder cancer/OR carcinoma of gallbladder/OR GBC.
- 5.
1 OR 2 OR 3.
- 6.
4 AND 5.
- 7.
Limit 6 to (Human and English language).
Titles and abstracts of articles found were screened, and full
Results
The PubMed search returned 52 unique articles of which 44 articles met the established inclusion criteria and were included in the analysis. Overall, these 44 articles investigated 80 candidate genes and 173 different polymorphisms in association with GBC. Fourteen studies investigated the role of gene–gene interactions in GBC susceptibility. Of the 80 genes studied, twenty five were involved in inflammatory pathway, eleven in DNA repair, twenty three in metabolic pathway, fifteen in hormonal
Discussion
Although there have been several descriptive reviews on this topic, to the best of authors’ knowledge, this is the first systematic review analyzing the effect of genetic determinants in GBC. In summary, we reviewed the available literature on genetic studies of GBC and conducted four independent meta-analyses for association between GBC and OGG1 rs1052133, TP53 rs1042522, GSTM1 and CYP1A1 rs1048943 polymorphisms. There was minimal evidence for a probable overall association between the studied
Conclusion
To conclude, although some genes show promise, the existing candidate gene studies in GBC susceptibility have so far been insufficient to confirm any association. The small number of studies decrease the potential generalization of results and also the statistical power [81], [82]. Thus, only preliminary conclusions can be drawn at this stage. Owing to its complex aetiology, it is extremely implausible that any single SNP or risk factor contributes significantly to the development of GBC in a
Conflict of interest
The authors declare that there are no conflicts of interest.
Acknowledgements
This research was supported [in part] by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (USA), Indian council of Medical Research (ICMR), DST and CSIR Government of India.
References (111)
- et al.
Malignancies of the biliary tree
Curr. Probl. Surg.
(1995) - et al.
Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer
Mol. Genet. Metab.
(2008) - et al.
IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population
Cancer Genet. Cytogenet.
(2008) - et al.
Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1-509C>T gene polymorphisms with gallbladder cancer
Hum. Immunol.
(2008) - et al.
Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat
Int. J. Cardiol.
(2006) - et al.
Pooling research results: benefits and limitations of meta-analysis
Jt. Comm. J. Qual. Improv.
(1999) - et al.
The design, execution, and interpretation of genetic association studies to decipher complex diseases
Am. J. Obstet. Gynecol.
(2002) - et al.
Polymorphisms of cytochrome P450 1A1, glutathione S-transferase class mu, and tumour protein p53 genes and the risk of developing gallbladder cancer in Japanese
Clin. Biochem.
(2007) - et al.
CYP7A1 (−204 A>C; rs3808607 and −469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population
Metabolism
(2010) - et al.
Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis
Cancer Detect. Prev.
(2004)
Carcinoma in the porcelain gallbladder: a relationship revisited
Surgery
Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder
Am. J. Gastroenterol.
Carcinoma of the gallbladder and extrahepatic bile ducts
Semin. Oncol.
Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas
Indian J. Gastroenterol.
Epidemiology and molecular pathology of gallbladder cancer
CA Cancer J. Clin.
Environmental pollutants in gallbladder carcinogenesis
J. Surg. Oncol.
Diet and gallbladder cancer: a case–control study
Eur. J. Cancer Prev.
Gallbladder cancer: an ‘Indian’ disease
Natl. Med. J. India
Complement receptor 1(A3650G RsaI and Intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population
Scand. J. Immunol.
CCR5 delta32 polymorphism: associated with gallbladder cancer susceptibility
Scand. J. Immunol.
Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer
J. Gastroenterol. Hepatol.
No association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in susceptibility to gallbladder cancer
DNA Cell Biol.
Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in north Indian population
Ann. Surg. Oncol.
Single nucleotide polymorphism in the ABCG8 transporter gene is associated with gallbladder cancer susceptibility
Liver Int.
Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of northern India
Cancer
Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population
J. Gastroenterol.
Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China
Carcinogenesis
Gallstones and the risk of biliary tract cancer: a population-based study in China
Br. J. Cancer
Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China
Cancer Res.
Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population
Eur. J. Cancer Prev.
Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: association with gallbladder cancer susceptibility
Int. J. Gastrointest. Cancer
Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in north India
Biomarkers
Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone disease
Cancer Biol. Ther.
Haplotype analysis of signal peptide (insertion/deletion) and XbaI polymorphisms of the APOB gene in gallbladder cancer
Liver Int.
Do TNFA-308 G/A and IL6-174 G/C gene polymorphisms modulate risk of gallbladder cancer in the north Indian population?
Asian Pac. J. Cancer Prev.
A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer
J. Gastroenterol.
Replicating genotype–phenotype associations
Nature
How meta-analysis increases statistical power
Psychol. Methods
Meta-analysis: principles and procedures
BMJ
Methods of Metaanalysis: Correcting Error and Bias in Research Findings
Freely associating
Nat. Genet.
Clinical epidemiological quality in molecular genetic research: the need for methodological standards
JAMA
Proposed guidelines for papers describing DNA polymorphism-disease associations
Hum. Genet.
A systematic review of the quality of genetic association studies in human sepsis
Intensive Care Med.
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies
J. Natl. Cancer Inst.
On estimating the relation between blood group and disease
Ann. Hum. Genet.
A method for meta-analysis of molecular association studies
Stat. Med.
Impact of violations and deviations in Hardy–Weinberg equilibrium on postulated gene–disease associations
Am. J. Epidemiol.
Assessment of cumulative evidence on genetic associations: interim guidelines
Int. J. Epidemiol.
Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer
J. Exp. Clin. Cancer Res.
Cited by (80)
The Global Burden of Early-Onset Biliary Tract Cancer: Insight From the Global Burden of Disease Study 2019
2024, Journal of Clinical and Experimental HepatologyThe role of circadian gene timeless in gastrointestinal cancers
2023, Gene ReportsCitation Excerpt :By 2022, the number of new cases of gallbladder cancer in the United States is estimated at 12,130, and the number of deaths from this cancer is 4400 (Siegel et al., 2021). Risk factors for this disease depend on the lifestyle and genetics of individuals, including gender, obesity, cholelithiasis (Folseraas and Boberg, 2016), the presence of some bacterial infections such as S. typhi (Ferreccio, 2012; Soofiyani et al., 2021), biliary polyps, calcification of the gallbladder wall (Baiu and Visser, 2018), and the occurrence of polymorphisms in genes related to GBC (Srivastava et al., 2011). According to searches from multiple databases, no studies have been reported on TIM genes (such as the role of polymorphisms and mutations) and their role in gallbladder cancer.
Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies
2021, Bulletin du CancerCitation Excerpt :The c.1482-19A>G (rs3769818) variant was detected in 9/100 patients while the rest of 91 patients harbored the A allele. The A allele of this SNP was reported in association with the risk of developing breast cancer [32], esophageal squamous cell carcinoma [33,34] and Gallbladder Cancer [35–38]. This is consistent with our results since breast cancer was observed in 20.5% of our cases as associated with solid tumor and all of them had the A allele.
STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma
2018, International Journal of Biochemistry and Cell BiologyCitation Excerpt :Gallbladder cancer (GBC) is the most commonly diagnosed malignancy of the biliary tract with an incidence of 2.5 in 100,000 individuals (Randi et al., 2006; Srivastava et al., 2011; Wu et al., 2014).
Gallbladder Cancer and Aflatoxin: Do We Have Sufficient Evidence?
2018, Gastroenterology